L. Mjornstedt et al., PROLONGED RAT-HEART ALLOGRAFT SURVIVAL AFTER TREATMENT WITH ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR OR A CALCIUM-ANTAGONIST, Scandinavian journal of urology and nephrology, 32(5), 1998, pp. 341-344
The effect in vivo of the angiotensin converting enzyme (ACE) inhibito
rs captopril and enalapril and the calcium antagonist verapamil was st
udied in an experimental model using rat heart allografts. Daily post-
transplant treatment of recipient rats (DA strain) with verapamil (75
mg kg(-1) day(-1)) or captopril (40 mg kg day) significantly prolonged
survival of allografts from donors (PVG/c strain) when compared with
an untreated control group (p < 0.05). No synergistic effect was obser
ved when the two drugs were used for combined treatment. An equipotent
does of enalapril (12.5 mg kg(-1) day(-1)) caused no change in allogr
aft survival of statistical significance. The results support the hypo
thesis that verapamil and captopril have effects on the immune reactiv
ity in vivo, and that this is not a characteristic shared by all ACE i
nhibitors.